publicationMetadata:
  pmid: "36420221"
  title: "Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype"
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research → antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    
    This is clearly a laboratory research study involving molecular biology techniques, cell culture,
    genetic manipulation, and biochemical assays. The methods section describes extensive use of
    research tools including cell lines, genetic reagents (PMOs), computational tools for analysis,
    antibodies for detection, and various commercial assay kits. Multiple tool types are expected
    across antibodies, cell lines, genetic reagents, and computational tools categories.
  overallAssessment: |
    This is a laboratory research publication focused on developing antisense oligonucleotide therapy
    for NF2-related schwannomatosis. The study involves extensive experimental work including cell culture,
    genetic manipulation, protein analysis, and phenotypic assays. Research tools are essential and
    extensively used throughout the methodology. The mining system appears to have failed completely
    as no tools were identified despite clear usage of multiple tool categories in the methods section.

toolValidations: []

potentiallyMissedTools:
  - toolName: "HeLa cells"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "The expression vector was transfected into HeLa cells (Lipofectamine LTX with Plus Reagent, Invitrogen) according to the manufacturer's instructions."
    whyMissed: "Standard cell line name not captured by mining patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "CLC-workbench"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Variants were validated by Sanger sequencing and analyzed using CLC-workbench (Qiagen, Hilden, Germany)"
    whyMissed: "Software name with vendor information not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "PredictProtein"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Analyses of in silico protein modifications by the exon skipping were performed using the web-server version of PredictProtein (https://www.PredictProtein.org)"
    whyMissed: "Web-based computational tool with URL not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "GraphPad Prism"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Statistical analysis was carried out using GraphPad Prism software v7."
    whyMissed: "Statistical software with version number not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Monoclonal ANTI-FLAG M2 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Flag expression was assessed by western blot (Monoclonal ANTI-FLAG M2 antibody, Sigma-Aldrich, St. Louis, MO)."
    whyMissed: "Antibody with clone designation and vendor not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "PMOs"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The 25-mer-specific PMOs for four patients with splicing variants, and a pair of PMOs to induce exon skipping of exons 4, 8, and 11 of the NF2 gene were designed"
    whyMissed: "Phosphorodiamidate morpholino oligomers abbreviation not captured"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "Gateway Gene Cloning system"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The NF2 gene was cloned using the Gateway Gene Cloning system (Invitrogen)"
    whyMissed: "Commercial cloning system with vendor not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "FLAG Tag Expression Vector"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The NF2 gene was cloned using the Gateway Gene Cloning system (Invitrogen) after treatment to induce the exon-skipping to an FLAG Tag Expression Vector."
    whyMissed: "Expression vector with specific tag not captured"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "Lipofectamine LTX with Plus Reagent"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The expression vector was transfected into HeLa cells (Lipofectamine LTX with Plus Reagent, Invitrogen)"
    whyMissed: "Transfection reagent with vendor not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Endo-Porter"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Endo-Porter (Gene Tools) was used as vehicle to deliver PMOs into cells at 6 μM"
    whyMissed: "Delivery reagent with vendor not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Phalloidin"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "An actin immunocytochemistry assay was performed to study the cytoskeletal organization after PMO treatment using Phalloidin (Molecular Probes [Eugene, OR], Invitrogen [Waltham, MA])."
    whyMissed: "Fluorescent probe for actin staining with vendor not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "AClick-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Molecular Probes, Invitrogen) was used, according to the manufacturer's protocol, to determine cell proliferation."
    whyMissed: "Commercial assay kit with full product name not captured"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "RealTime-Glo MT Cell Viability Assay"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Cell viability was assessed using RealTime-Glo MT Cell Viability Assay (Promega) following the manufacturer's instructions."
    whyMissed: "Commercial viability assay with vendor not captured"
    confidence: 1.0
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "term"
    pattern: "HeLa cells?|HEK293T?|MCF-?7|A549|U2OS|293T?"
    toolType: "cell_line"
    examples: ["HeLa cells"]
    reasoning: "Common cell line names that appear in methods sections with standard nomenclature"

  - patternType: "context_phrase"
    pattern: "analyzed using ([A-Z][a-zA-Z-]+(?:\\s+[a-zA-Z-]+)*)"
    toolType: "computational_tool"
    examples: ["analyzed using CLC-workbench"]
    reasoning: "Software tools are often mentioned with 'analyzed using' context phrase"

  - patternType: "context_phrase"
    pattern: "performed using the web-server version of ([A-Z][a-zA-Z]+)"
    toolType: "computational_tool"
    examples: ["performed using the web-server version of PredictProtein"]
    reasoning: "Web-based computational tools have specific context patterns"

  - patternType: "vendor_indicator"
    pattern: "([A-Z][a-zA-Z\\s-]+)\\s*\\([^)]*(?:Invitrogen|Sigma-Aldrich|Qiagen|Promega|Gene Tools|Molecular Probes)[^)]*\\)"
    toolType: "general"
    examples: ["Monoclonal ANTI-FLAG M2 antibody, Sigma-Aldrich", "CLC-workbench (Qiagen, Hilden, Germany)"]
    reasoning: "Tools are often mentioned with vendor information in parentheses"

  - patternType: "naming_convention"
    pattern: "([A-Z][a-zA-Z]+-[A-Z][a-zA-Z]+\\s+[A-Z0-9]+\\s+antibody)"
    toolType: "antibody"
    examples: ["Monoclonal ANTI-FLAG M2 antibody"]
    reasoning: "Antibodies often follow specific naming patterns with clone designations"

  - patternType: "term"
    pattern: "PMOs?|morpholino oligomers?|antisense oligonucleotides?"
    toolType: "genetic_reagent"
    examples: ["PMOs"]
    reasoning: "Antisense reagents have specific terminology that should be captured"

  - patternType: "context_phrase"
    pattern: "([A-Z][a-zA-Z\\s-]+(?:Kit|System|Reagent))\\s*\\([^)]*[A-Z][a-zA-Z]+[^)]*\\)"
    toolType: "genetic_reagent"
    examples: ["Gateway Gene Cloning system (Invitrogen)", "Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Molecular Probes, Invitrogen)"]
    reasoning: "Commercial kits and systems are often mentioned with vendor information"

  - patternType: "context_phrase"
    pattern: "statistical analysis was carried out using ([A-Z][a-zA-Z\\s]+(?:software|v\\d+)?)"
    toolType: "computational_tool"
    examples: ["statistical analysis was carried out using GraphPad Prism software v7"]
    reasoning: "Statistical software is commonly mentioned in this specific context"

  - patternType: "term"
    pattern: "Phalloidin|DAPI|Hoechst|propidium iodide"
    toolType: "antibody"
    examples: ["Phalloidin"]
    reasoning: "Common fluorescent probes and stains used in microscopy"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 13
  newPatternsCount: 9
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - Complete mining failure: No tools were identified despite extensive tool usage in methods
    - Missing cell line detection: HeLa cells clearly mentioned but not captured
    - Missing computational tool detection: Multiple software tools (CLC-workbench, PredictProtein, GraphPad Prism) not captured
    - Missing antibody detection: Monoclonal ANTI-FLAG M2 antibody and Phalloidin not captured
    - Missing genetic reagent detection: PMOs, vectors, transfection reagents, and commercial kits not captured
    - Vendor information not utilized: Many tools mentioned with clear vendor/manufacturer information
    - Pattern coverage gaps: Current patterns appear inadequate for this type of molecular biology research
  recommendations: |
    This publication represents a complete mining failure with 13+ research tools clearly present but not detected.
    The mining system needs significant improvement in pattern coverage for:
    1. Standard cell line nomenclature (HeLa, HEK293, etc.)
    2. Software tools mentioned with "analyzed using" or "performed using" context
    3. Commercial reagents and kits with vendor information in parentheses
    4. Antibodies with clone designations and vendor information
    5. Genetic reagents including vectors, transfection reagents, and delivery systems
    6. Web-based computational tools with URLs
    7. Statistical software with version numbers
    
    All 13 identified tools should be added to the database as they represent genuine research tools
    used experimentally in this study. The suggested patterns should be implemented to prevent
    similar mining failures in molecular biology publications. No observations were extracted
    as the Results and Discussion sections were not available in the input data.
